In this study, we evaluated the activity of Andean Shilajit and, for the first time, we reported the effects of its novel fractions on neuritogenesis and aggregation of human tau protein, in consideration of the fact that the damage to neurons, synaptic transmission, and, consequently, to memory processes induced by tau protein aggregation is central to developing AD. This evidence concerns the gene MAPT and Alzheimer disease.